Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
CRBU
#3070
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.55%
Variazione Mensile
+21.79%
Variazione di 6 mesi
-5.94%
Variazione Annuale
+62.39%
Chiusura Precedente
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
Volume
25
Mercati
Mercato Azionario Statunitense
Salute
CRBU
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
60.66 M
61.3 M
90.31 M
93 M
—
Valuation ratios
Enterprise value
674.99 M
346.85 M
451.89 M
131.58 M
485.86 M
Price to earnings ratio
—
-4.03
-4.04
-0.96
-3.61
Price to sales ratio
—
29.02
11.92
14.37
58.57
Price to cash flow ratio
—
4.42
4.41
1.04
4.22
Price to book ratio
—
1.34
1.12
0.57
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.27
0.24
0.48
0.65
Return on equity %
0.17
0.33
0.28
0.59
0.84
Return on invested capital %
445.36
461.56
417.75
680.35
—
Gross margin %
100
100
100
100
400
Operating margin %
697.84
768.17
336.63
1 667.16
6 816.98
EBITDA margin %
—
—
—
—
—
Net margin %
697.26
717.79
296.05
1 491.95
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
15.15
9.25
11.97
7.16
26.99
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0.03
0.09
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
1.5
1.26
1.53
1.36
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.21
5.05
2.76
8.74
Net current asset value per share
—
4.28
4.59
2.43
8.51
Tangible book value per share
—
4.95
4.99
2.8
8.45
Working capital per share
—
3.82
4.21
2.09
7.25
Book value per share
—
4.95
4.99
2.8
8.45
Notizie
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Il CLO di Caribou Biosciences vende azioni CRBU per 13.598$
Caribou Biosciences CLO sold $13,598 in CRBU stock
Il CTO di Caribou Biosciences Kelly vende azioni per 6.100$
Caribou Biosciences CTO Kelly sells $6.1k in shares
CMO di Caribou Biosciences vende azioni CRBU per 2.100$
Khan, CBO di Caribou Biosciences, vende azioni per 13.598$
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?